Document is current
Any future updates will be listed below
-
Authors
Svoboda, Steven A. https://orcid.org/0000-0002-8687-1178
Ghamrawi, Rima I. https://orcid.org/0000-0001-6325-7581
Owusu, Dorellie A.
Feldman, Steven R. https://orcid.org/0000-0002-0090-6289
- License Information
-
More Information
Article History
First Online: 18 May 2020
Compliance with Ethical Standards
:
: No external funding was used to conduct this study or prepare this manuscript.
: Dr. Steven Feldman has received research, speaking, and/or consulting support from a variety of companies, including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Abbvie, Samsung, Janssen, Lilly, Menlo, Merck, Novartis, Regeneron, Sanofi, Novan, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate, and the National Psoriasis Foundation. He is founder and majority owner ofand founder and part owner of Causa Research, a company dedicated to enhancing patients’ adherence to treatment. S.A. Svoboda, D.A. Owusu, and R.I. Ghamrawi have no conflicts of interest that are directly relevant to the content of this article.
